학술논문
Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial
Document Type
Article
Author
Source
In: The Lancet Oncology . (The Lancet Oncology, May 2024, 25(5):588-602)
Subject
Language
English
ISSN
14745488
14702045
14702045